MENU

ANVS Annovis Bio Forecast, Technical & Fundamental Analysis

a developer of drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders

Industry Biotechnology
ANVS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
ANVS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ANVS is expected to report earnings to fall 60.02% to -38 cents per share on April 08

Annovis Bio ANVS Stock Earnings Reports
Q4'24
Est.
$-0.39
Q3'24
Missed
by $0.46
Q2'24
Beat
by $0.19
Q1'24
Beat
by $0.10
Q4'23
Missed
by $0.83
The last earnings report on November 11 showed earnings per share of -97 cents, missing the estimate of -50 cents. With 123.56K shares outstanding, the current market capitalization sits at 96.17M.
A.I. Advisor
published General Information

General Information

a developer of drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
101 Lindenwood Drive
Phone
+1 484 875-3192
Employees
6
Web
https://www.annovisbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

ANVS and Stocks

Correlation & Price change

A.I.dvisor tells us that ANVS and ADXN have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANVS and ADXN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANVS
1D Price
Change %
ANVS100%
-5.94%
ADXN - ANVS
33%
Poorly correlated
-4.98%
EWTX - ANVS
33%
Poorly correlated
-1.17%
TNYA - ANVS
29%
Poorly correlated
-3.35%
ZVSA - ANVS
26%
Poorly correlated
-9.60%
ATXI - ANVS
26%
Poorly correlated
-3.59%
More